Advisory Alpha’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Buy
4,823
+951
+25% +$91.1K 0.01% 364
2025
Q4
$372K Buy
3,872
+688
+22% +$66.8K 0.01% 370
2025
Q3
$304K Buy
3,184
+521
+20% +$47.9K 0.01% 411
2025
Q2
$232K Buy
2,663
+357
+15% +$30.3K 0.01% 434
2025
Q1
$207K Buy
+2,306
New +$206K 0.01% 434
2020
Q4
Sell
-1,014
Closed -$107K 426
2020
Q3
$107K Buy
+1,014
New +$102K 0.02% 142
2020
Q2
Sell
-1,100
Closed -$105K 400
2020
Q1
$105K Hold
1,100
0.03% 139
2019
Q4
$130K Buy
1,100
+452
+70% +$49.6K 0.03% 176
2019
Q3
$69.2K Buy
+648
New +$67.6K 0.02% 209
2019
Q2
Sell
-643
Closed -$56.7K 432
2019
Q1
$56.7K Buy
+643
New +$57.5K 0.02% 219

Other funds holding MDT

Advisory Alpha's MDT Position: Q1 2026 in Review

Advisory Alpha increased its Medtronic (MDT) stake by 25% in Q1 2026, buying an estimated $91.1K and bringing the position to 4,823 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #364.

Advisory Alpha first reported a position in MDT in Q1 2019 and has held it in 10 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Advisory Alpha held 4,823 shares of Medtronic worth $418K as of Q1 2026.
  • Advisory Alpha bought 951 Medtronic shares in Q1 2026, an estimated $91.1K.
  • Medtronic made up 0.01% of Advisory Alpha's portfolio in Q1 2026, its #364 holding.
  • Advisory Alpha first reported a position in Medtronic in Q1 2019 and has held it in 10 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.